Barnes Dennig Private Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$963 Hold
40
﹤0.01% 330
2026
Q1
$1.12K Hold
40
﹤0.01% 297
2025
Q4
$996 Hold
40
﹤0.01% 306
2025
Q3
$1.02K Hold
40
﹤0.01% 293
2025
Q2
$970 Sell
40
-1,484
-97% -$34.6K ﹤0.01% 289
2025
Q1
$38.6K Buy
+1,524
New +$39.9K 0.06% 81

Other funds holding PFE

Barnes Dennig Private Wealth Management's PFE Position: Q2 2026 in Review

Barnes Dennig Private Wealth Management held its Pfizer (PFE) position steady in Q2 2026 at 40 shares worth $963. The position accounts for ﹤0.01% of the portfolio, ranked #330.

Barnes Dennig Private Wealth Management first reported a position in PFE in Q1 2025 and has held it in 6 quarters since. The position peaked at $38.6K in Q1 2025. 1,285 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Barnes Dennig Private Wealth Management held 40 shares of Pfizer worth $963 as of Q2 2026.
  • Barnes Dennig Private Wealth Management left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up ﹤0.01% of Barnes Dennig Private Wealth Management's portfolio in Q2 2026, its #330 holding.
  • Barnes Dennig Private Wealth Management first reported a position in Pfizer in Q1 2025 and has held it in 6 quarters since.
  • Barnes Dennig Private Wealth Management's Pfizer position peaked at $38.6K in Q1 2025.
  • 1,285 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Barnes Dennig Private Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.